课题基金 / 基金详情

The CRISP Trial: an RCT of risk assessment and decision support to implement risk-stratified colorectal cancer screening in primary care.

The CRISP Trial: an RCT of risk assessment and decision support to implement risk-stratified colorectal cancer screening in primary care.
CRISP 试验:一项风险评估和决策支持的随机对照试验,旨在在初级保健中实施风险分层结直肠癌筛查。
批准号:
nhmrc : GNT1121104
负责人:
A/Pr Marie Pirotta
金额:
$93.66万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2017
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2017-01-01 至 --

项目摘要

项目成果

A/Pr Marie Pirotta的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
There is a mismatch between people’s use of bowel cancer screening tests through faecal occult blood testing or colonoscopy and their individual risk of bowel cancer. Building on the work of our NHMRC Centre for Research Excellence (CRE) on Optimising Colorectal Cancer Screening, this trial will test the effect of an electronic risk assessment tool, implemented in general practice, on use of the most appropriate screening test for bowel cancer based on a person’s risk of developing the condition
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The CRISP Trial: an RCT of risk assessment and decision support to implement risk-stratified colorectal cancer screening in primary care.
  • 批准号:
    nhmrc : 1121104
  • 项目类别:
    Project Grants
  • 资助金额:
    $64.04万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Marie Pirotta
  • 依托单位:
Optimising primary care management of knee osteoarthritis: the PARTNER project.
  • 批准号:
    nhmrc : 1115720
  • 项目类别:
    Partnerships
  • 资助金额:
    $78.41万
  • 财政年份:
    2016
  • 负责人:
    A/Pr Marie Pirotta
  • 依托单位:
Optimising primary care management of knee osteoarthritis: the PARTNER project.
  • 批准号:
    nhmrc : GNT1115720
  • 项目类别:
    Partnerships
  • 资助金额:
    $115.54万
  • 财政年份:
    2016
  • 负责人:
    A/Pr Marie Pirotta
  • 依托单位:
Centre of Research Excellence in Translation of Research into Improved OUtcomes in Musculoskeletal Pain & Health (CRE TRIUMPH)
  • 批准号:
    nhmrc : 1079078
  • 项目类别:
    Centres of Research Excellence
  • 资助金额:
    $174.75万
  • 财政年份:
    2015
  • 负责人:
    A/Pr Marie Pirotta
  • 依托单位:
国内基金
海外基金
基于移动健康技术干预动脉粥样硬化性心血管疾病高危人群的随机对照现场试验:The ASCVD Risk Intervention Trial
  • 批准号:
    81973152
  • 项目类别:
    面上项目
  • 资助金额:
    54.0万元
  • 批准年份:
    2019
  • 负责人:
    胡东生
  • 依托单位: